Wall Street May Be Selling the Opportunity of a Decade

Markets have a fascinating habit of confusing temporary disappointment with permanent damage.

The same investors who celebrate companies at their peaks often abandon them when sentiment turns negative. Valuations become uncomfortable, expectations are revised, institutional money moves elsewhere, and even businesses with powerful competitive advantages suddenly find themselves under selling pressure.

Look at the names attracting attention now: Alphabet, Amazon, Bank of America, CoreWeave, Intel, Nvidia and SpaceX.

These are not obscure companies surviving on speculative promises. They represent some of the most consequential businesses in technology, finance, artificial intelligence and global commerce.

Their share-price weakness raises a question worth examining:

Are investors witnessing the deterioration of these businesses, or simply an opportunity created by excessive pessimism?

My inclination is to investigate the second possibility seriously.

Long-term wealth is rarely created by buying everything that is popular. It is often created by recognising value when market sentiment temporarily turns against otherwise powerful businesses.

However, a falling share price alone does not make a stock cheap. The real opportunity emerges when the market’s expectations deteriorate faster than the underlying business.

That distinction could be particularly important in the present environment.

The selloff is not necessarily a verdict on the businesses

The recent decline is not entirely irrational. There are genuine concerns behind it. But the market may be pricing several different risks with the same blunt instrument: selling.

Consider what has happened:

• Alphabet: Shares suffered a record single-day decline after disappointing results and concerns about AI infrastructure spending, cash flow and the future of search. Yet Google Cloud revenue more than doubled in Q3-26.

• Amazon: Investors are questioning its massive AI capital expenditure, weak free cash flow and disappointing quarterly outlook. The company is investing heavily in infrastructure that could strengthen its long-term cloud position.

• Bank of America: A disappointing quarter, weaker trading revenues and a $1.2 billion regulatory penalty have hurt sentiment. This is a different investment story from the AI selloff, and governance risks deserve attention.

• CoreWeave: The AI infrastructure opportunity is enormous, but so is its financial risk. Heavy debt, borrowing costs and uncertain returns make this a speculative investment rather than an obvious bargain.

• Intel: Its nearly 29% one-day collapse reflects disappointing guidance, manufacturing challenges and weak PC demand. A turnaround is possible, but execution remains the central question.

• Nvidia: The AI chip leader has also suffered from the broader semiconductor selloff. However, its underlying demand outlook remains substantial, with management previously forecasting 70% revenue growth for the next fiscal year.

• SpaceX: Its investment case belongs in a separate category: launch services, satellite connectivity and space infrastructure. Its shares trade publicly following its June 2026 IPO, but a falling share price must be assessed against its IPO valuation and current financial disclosures.

The important point is that these are not seven identical opportunities. Some are established cash-generating giants, some are turnaround candidates, and some carry substantial financing risk.

Share The Listed Edge

Why this could be a long-term investing opportunity

I see five reasons to investigate these companies rather than dismiss them.

Market sentiment can change faster than business fundamentals.

A disappointing quarter can trigger institutional selling, algorithmic trading and stop-loss orders. Once selling gathers momentum, prices can fall much faster than the underlying earning power of a business.

The AI revolution is not disappearing because investors are nervous.

AI infrastructure requires chips, cloud computing, data centres, networking, electricity and software. The winners may change, but the underlying transformation is unlikely to disappear overnight.

Established businesses have advantages that newcomers cannot easily replicate.

Alphabet has distribution and data. Amazon has cloud infrastructure and commerce. Nvidia has an established computing ecosystem. Bank of America has a substantial banking franchise.

These advantages deserve long-term consideration.

Turnarounds can create disproportionate returns.

Intel is an interesting example. If manufacturing execution improves and its competitive position strengthens, today’s pessimism could eventually look excessive. But this is a turnaround bet, not a proven investment thesis.

Time can work in favour of patient investors.

An investor buying during pessimism does not need an immediate recovery. The objective is to acquire a good business at a reasonable valuation and allow earnings growth to compound.

My investment approach: Don’t buy the dip. Buy the opportunity.

I would not purchase all these stocks simply because they have fallen, instead, I would divide them into three categories:

• Core long-term candidates: Alphabet, Amazon and Nvidia. Study valuations, cash flows and earnings visibility before accumulating.

• Value and turnaround candidates: Bank of America and Intel. Look for evidence that the underlying problems are manageable.

• Higher-risk growth candidates: CoreWeave and SpaceX. Demand stronger valuation discipline and closer monitoring of financing, cash generation and execution.

I would also use staggered accumulation rather than committing the entire investment immediately.

Next big opportunity may be hiding the biggest disappointments

There is an important difference between buying a falling stock and buying a business whose future remains considerably stronger than its current market price suggests.

The former is speculation. The latter is investing.

Alphabet, Amazon and Nvidia could offer attractive long-term opportunities if their valuations adequately compensate for the risks. Bank of America and Intel deserve separate fundamental assessments. CoreWeave requires considerably more caution, while SpaceX needs an independent valuation framework.

My thesis is simple: Don’t confuse a correction in market prices with the destruction of long-term business value. Some of these biggest market disappointments could become tomorrow’s strongest investment stories.

But the real opportunity will belong to investors who distinguish temporary setbacks from permanent impairment, value from hype, and patience from blind conviction.

The objective is not to catch the bottom. It is to own the right businesses before the market recognises their value again.

Leave a comment

Disclaimer: This article is for educational and informational purposes only. It is not investment advice or a recommendation to buy or sell any security. A significant price decline does not automatically indicate undervaluation. Company fundamentals, financial statements, debt, cash flows, competitive positioning and valuations must be independently examined. Market conditions and investment theses can change. Data and market developments should be independently verified before making investment decisions.

Extendicare offers exposure to a growing healthcare services market, with opportunities to expand through acquisitions, organic growth and operational efficiencies. Its outlook is constructive if the company integrates its acquisitions successfully, protects margins and converts revenue growth into sustainable cash generation.

Subscribe now

Business model: Three complementary engines

Extendicare operates through three principal segments, providing exposure to different aspects of Canada’s senior-care market.

Home healthcare: Through ParaMed and its expanded home healthcare operations, the company provides nursing, rehabilitation and personal support services. This segment has become a major growth driver following the acquisitions of Closing the Gap and CBI Home Health. Demand for care delivered at home offers opportunities to expand service volumes.

Long-term care: Extendicare operates long-term care homes providing accommodation, nursing and personal care. Occupancy remained strong at 98% in Q2-2026. Revenue growth can benefit from funding increases, improved occupancy and additional capacity, but labour, regulatory and operating-cost pressures are also there.

Managed services: Extendicare Assist and its SGP Purchasing Network provide management, consulting and purchasing services to care providers. This segment offers a complementary revenue stream, with managed services potentially benefiting from scale without requiring the company to own or operate every facility it serves.

The combination gives Extendicare a broader business platform than a traditional long-term care operator.

Financial performance: Strong growth, with integration

Extendicare’s Q2-2026 results demonstrated a substantial increase in operating scale. The figures below are in Canadian dollars unless stated otherwise.

• Revenue: C$611.0 million, up from C$383.4 million in Q2-2025.

• Net operating income: C$86.2 million, compared with C$55.0 million.

• Adjusted EBITDA: C$68.3 million, up 71.7% year over year.

• Adjusted funds from operations: C$36.5 million, up from C$24.8 million.

The company also incurred C$8.1 million in interest and costs associated with the early repayment of long-term debt.

For the first six months of 2026, revenue reached C$1.076 billion and adjusted EBITDA was C$121.2 million. AFFO increased to C$69.2 million from C$44.6 million in the corresponding 2025 period.

These results indicate that the business is expanding and improving its operating earnings. The next test is whether the acquired businesses can sustain their contribution.

Subscribe "Equity Reads" also

Acquisition strategy: Growth opportunity and financial obligation

The acquisitions substantially increased the company’s home healthcare volumes and strengthened its position across the continuum of senior care. They also created opportunities to combine administrative functions, improve purchasing efficiency and expand its reach.

But acquisitions are not automatically value-creating. The company must generate enough additional cash flow to justify the purchase price and financing costs.

Successful integration could support further earnings growth. Disappointing margins, persistent cost pressures or slower-than-expected cash generation would weaken that outlook.

Industry outlook and growth drivers

Canada’s ageing population provides a long-term demand driver for home healthcare and residential care. Extendicare’s strategy of expanding across both markets positions it to participate in this trend.

The principal growth drivers are:

• Rising demand for home-based nursing and personal support.

• Improvements in operating efficiency with acquired businesses.

• Funding adjustments and occupancy in long-term care.

• Expansion of managed services and purchasing-network activity.

• Opportunities to add scale.

These are the structural opportunities, but labour availability, wage inflation, provincial funding decisions and regulatory requirements will influence how much of the demand growth converts into profit.

Technical outlook: Recovery requires confirmation

The available market data show that Extendicare’s share price was below its reported 50-day moving average of approximately C$29.80 and 200-day moving average of approximately C$29.80. Its reported RSI, indicating neutral momentum rather than a deeply oversold reading.

The technical setup therefore calls for caution despite the improving operating results.

• Near-term support to monitor: C$26.50–27.00.

• Initial resistance: C$29.80–30.00.

A sustained move above the moving-average zone would provide an initial sign of recovery. Failure to hold support could extend the correction and delay the market’s recognition of the company’s improving fundamentals.

Price targets and investment scenarios

The following are illustrative research estimates, not company guidance or verified analyst consensus. They assume successful integration, continued operating growth and no material deterioration in funding, costs or financing conditions.

• Short term: C$29–31. A recovery toward this zone would require the stock to stabilise and reclaim its initial resistance area.

• Medium term: C$32–36. This range depends on improving technical momentum and evidence that acquisition-related earnings gains are sustainable.

• Long term: C$38–42. This scenario assumes continued growth in cash flow, successful integration and a valuation that remains supportive.

These targets should be reassessed after the next earnings release, particularly in light of changes in debt, AFFO, margins and management guidance. Extendicare’s Q3-2026 results are scheduled for release on 6 November 2026, making that an important upcoming checkpoint.

Principal risks

The investment thesis could weaken if acquisition integration takes longer than expected, labour costs rise faster than reimbursements, or government funding fails to keep pace with operating expenses.

Higher debt and interest costs could also constrain cash available for reinvestment and dividends. Furthermore, a stock trading below its key moving averages may remain under pressure even if reported earnings improve.

Investors should distinguish between business growth, and shareholder returns. Revenue expansion alone is insufficient if it requires substantial capital, increases financial risk or fails to produce attractive returns.

A growing business, but execution will determine returns

Extendicare offers an investment case built around long-term demand for senior care, an expanding home healthcare platform and stronger operating earnings. Q2-2026 results show that the business has achieved considerable scale, while acquisitions provide further opportunities for growth.

The Listed Edge view: Extendicare merits consideration for a medium- to long-term research watchlist. Its growth prospects are constructive, and valuation, integration, debt and technical resistance remain important constraints. A sustained recovery in price action, supported by continued earnings and cash-flow progress, would strengthen the investment case.

Leave a comment

Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. The analysis, financial data and illustrative price targets are based on publicly available information and are subject to change and uncertainty. The writer has no association, affiliation or business connection with the company discussed. Readers should conduct their own due diligence before investing. The Listed Edge and the writer accept no responsibility for investment losses arising from reliance on this report.

Thinking beyond the Stock

Identifying a good company is only part of the challenge but understanding the economic environment, recognising market expectations, managing risk and knowing when to change course can be equally important.

Stanley Druckenmiller, one of the most prominent macro investors of his generation, built his reputation by combining these disciplines. Rather than focusing exclusively on individual companies, he studies the interaction between economic growth, interest rates, liquidity, government policy and financial markets.

His career spans the creation of Duquesne Capital Management, his collaboration with George Soros at the Quantum Fund and his subsequent transition to Duquesne Family Office.

His experience offers a valuable lesson: successful investing is not simply about predicting the future. It is about identifying opportunities, allocating capital intelligently and responding when the evidence changes.

From Duquesne Capital to Duquesne Family Office

After studying economics at Bowdoin College and working in equity research and portfolio management, Stanley Druckenmiller founded Duquesne Capital Management in 1981, reportedly with around $1 million in assets.

In 1988, he joined George Soros’s Quantum Fund. Their most famous trade came in 1992, when they bet against the British pound, demonstrating how economic fundamentals and unsustainable government policies can create major investment opportunities.

Druckenmiller also learned from mistakes. During the late-1990s technology boom, he sold tech stocks too early, re-entered near the market peak and suffered losses—an example of how the fear of missing out can undermine discipline.

In 2010, he returned outside investors’ capital and closed Duquesne Capital, continuing to invest through Duquesne Family Office, which manages his personal wealth.

Understanding His Investment Philosophy

Druckenmiller’s approach is not a mechanical formula. It combines macroeconomic analysis, fundamental research, market behaviour and active portfolio management.

Liquidity and central-bank policy matter; Interest rates, credit availability and monetary policy influence asset valuations and investors’ willingness to take risks. Druckenmiller therefore considers the broader financial environment before committing capital.

A company may have strong earnings prospects, but its stock can still struggle if valuations are excessive or financial conditions deteriorate.

The lesson is to examine both the quality of the business and the environment in which it operates.

Think across markets, not just stocks; Druckenmiller’s macro approach considers equities, bonds, currencies and commodities. Sometimes an economic view can be expressed more directly through a currency or bond position than through an individual company.

This flexibility helps investors avoid forcing an investment simply because they feel compelled to participate in a particular market.

Concentrate when conviction is justified; Druckenmiller has argued that investors should identify their strongest opportunities rather than distribute capital indiscriminately across numerous ideas.

However, concentration must be accompanied by rigorous risk management. His professional approach is not a justification for retail investors to place excessive amounts of money into a single stock.

The practical lesson is to distinguish between a genuinely well-supported investment thesis and confidence driven by enthusiasm or recent price performance.

Change your mind when the evidence changes; An investment thesis is a hypothesis, not a permanent commitment. A company’s competitive position can weaken, valuations can become excessive, and macroeconomic conditions can change.

Druckenmiller’s approach emphasises responding to new information rather than defending an earlier decision simply because capital has already been committed.

Share

Risk management is part of the investment thesis; Risk involves more than the percentage invested in a stock. Correlation between holdings, liquidity, leverage, volatility and the possibility of sudden market changes also matter.

The objective is not to avoid every loss. It is to prevent a mistaken view from causing disproportionate damage to the portfolio.

Three Experiences That Define His Career

The 1992 British pound trade: Recognising an unsustainable policy

UK struggled to maintain sterling’s position within the European Exchange Rate Mechanism as economic conditions put pressure on its currency policy.

Druckenmiller and Soros recognised the tension between the government’s exchange-rate commitment and the economic conditions required to defend it. Their position against sterling became one of the most famous macro trades in financial history.

Government policy and economic reality can diverge. When a policy becomes increasingly difficult to sustain, the gap may create an investment opportunity. But timing, leverage and the cost of maintaining a position remain critical risks.

The technology bubble: When FOMO overrides discipline

During the late-1990s technology boom, Druckenmiller initially reduced exposure to technology stocks because he considered valuations excessive. As prices continued rising, he became frustrated by the gains he was missing and re-entered the market near its peak.

This episode is particularly instructive because it was not a triumph. It showed how even experienced investors can abandon their own analysis when the market moves against their expectations.

Three behavioural traps were at work: fear of missing out, regret over missed gains and the assumption that a powerful trend would continue.

A stock’s continued rise does not automatically invalidate a valuation concern. Investors should avoid confusing a rising price with improving investment value.

Looking beyond fashionable investment themes

In a Morgan Stanley interview, Druckenmiller discussed opportunities beyond the crowded AI trade. One example was Teva Pharmaceuticals, which he described as an apparently unexciting generic-drug business trading at roughly six times earnings at the time of the discussion.

The point is not that every low-multiple pharmaceutical company is attractive. Rather, investors should investigate situations where valuation, business prospects and market expectations appear misaligned.

Instead of asking only which stock is rising fastest, ask what the market may be overlooking—and what evidence could cause investors to reconsider their assumptions.

Practical Lessons for Individual Investors

Druckenmiller’s professional strategies may involve concentration, derivatives and leverage that are unsuitable for many retail investors. Nevertheless, several principles can be applied to ordinary stock investing.

First, build a thesis before buying. Understand the business, earnings drivers, valuation and industry outlook. Identify what the market expects and what evidence could invalidate your view.

Second, consider the economic environment. Interest rates, liquidity, inflation and currency movements can affect even fundamentally strong companies. A good business purchased at an excessive valuation can still produce disappointing returns.

Third, size positions according to risk. Strong conviction should not justify risking a disproportionate share of your capital. Set position limits and consider how much you could lose if the thesis fails.

Fourth, distinguish being early from being wrong. Stock may temporarily move against a sound thesis, but this does not mean every losing position deserves more time. Reassess the facts instead of automatically averaging down.

Fifth, recognise emotional mistakes. FOMO, regret, overconfidence and attachment to a stock can undermine sound research. Druckenmiller’s technology-boom experience demonstrates that knowledge alone does not eliminate behavioural errors.

Finally, evaluate your process, not just the outcome. A profitable trade may have been poorly reasoned, while a well-researched investment can still lose money. Record your rationale, risk limits and exit conditions, and review decisions over a series of trades.

A Simple Investment Checklist Inspired by Druckenmiller

Before entering a position, ask:

• Do I understand the business and its earnings drivers?

• Are interest rates, liquidity and industry conditions supportive or deteriorating?

• Is the valuation reasonable relative to expected growth and risk?

• Does price behaviour support the thesis, or contradict it?

• What evidence would invalidate my investment view?

• Is my position size appropriate if the trade goes wrong?

• Am I acting on evidence rather than FOMO or social-media excitement?

• Will I reassess the investment when new facts emerge?

This is an educational checklist inspired by publicly discussed principles, not a proprietary Duquesne investment model.

Conclusion: Conviction Matters, but Adaptability Matters More

Stanley Druckenmiller’s career demonstrates that successful investing requires more than bold bets. It demands independent thinking, sound research, precise timing and disciplined risk management.

The 1992, pound trade highlights the rewards of recognising market mispricing, while his technology-boom mistakes reveal how fear of missing out can derail even experienced investors.

For individual investors, the lesson is simple: Think independently, act with conviction when evidence supports it, protect capital when you are wrong, and never be afraid to change your mind.

Long-term success is not about being right every time—it is about making better decisions consistently and managing mistakes wisely.

Stay Connected!

Leave a comment

Investment overview

Affirm is a US fintech company best known for Buy Now, Pay Later, allowing consumers to pay for purchases in instalments. Its wider platform includes the Affirm Card, direct-to-consumer financing and merchant payment integrations. Revenue comes from merchant fees, consumer interest, loan sales and servicing.

The investment case is that Affirm can evolve from a checkout option into a broader consumer-payments platform. More merchants, repeat customers and everyday card use could support growth.

Financial snapshot

Affirm’s fiscal 2026 ended 30 June 2026. Revenue rose to $4.26 billion from $3.22 billion, while gross merchandise volume (GMV) increased to $50.2 billion from $36.7 billion. Operating income improved to $417 million, compared with an $87 million operating loss in FY2025.

Reported FY2026 net income of about $1.93 billion needs caution: it included a roughly $1.44 billion income-tax benefit and should not be treated as recurring earnings. Credit-loss provisions also increased to approximately $796.7 million from $616.7 million. Investors should focus on revenue less transaction costs, operating performance, credit metrics and cash generation—not headline net income alone.

What could drive growth?

BNPL adoption: Consumers may value clear instalment schedules, while merchants use financing to support checkout conversion and sales. Growth depends on the benefits outweighing merchant fees and credit risk.

Affirm Card and repeat usage: Broader use beyond partner checkouts could lift transaction frequency and customer engagement. The test is whether additional usage earns attractive returns after funding and credit costs.

Merchant distribution: Affirm reported approximately 571,000 active merchants as on 30 June 2026. Its five largest merchant and platform partners represented 44% of GMV, Amazon alone accounted for 22%. Diversification is improving, but major-partner exposure remains important.

Data-driven underwriting and operating leverage: Transaction data and machine-learning models may improve risk assessment and fraud controls. If revenue grows faster than operating expenses without a deterioration in loan quality, margins could strengthen. These benefits must be demonstrated through results, not assumed.

Visit "Equity Reads" for Indian equities

Key risks

The key risks include rising delinquencies and defaults if unemployment increases or household finances weaken, while higher borrowing costs could compress margins and restrict lending growth. Intense competition from PayPal, Block’s Afterpay, Klarna and credit-card issuers may pressure pricing and increase customer acquisition costs. Elevated valuation expectations leave the stock vulnerable to a correction if growth slows or margins disappoint, even if the business continues to perform well.

Chart View: Affirm Holdings (NASDAQ: AFRM)

The GMMA chart suggests AFRM is recovering from an earlier downtrend, but recent price action indicates consolidation rather than a confirmed breakout. Moving-average alignment and trading volume will be important for assessing renewed momentum.

• Short term: Cautiously bullish if the recovery holds, volatility may persist.

• Medium term: Constructive if the stock forms higher highs and higher lows.

• Long term: The chart outlook depends on a sustained uptrend, while business growth, profitability and credit quality remain key fundamental drivers.

Closing view — AFRM merits monitoring, but investors should avoid chasing sharp rallies. A volume-backed breakout or a pullback that stabilises near support could offer a more disciplined entry opportunity. These are conditional observations, not confirmed trading signals.

Visit "Third Publication" also

Investment Thesis

Affirm is building a scalable fintech platform, supported by growing revenue and GMV, positive operating income, and expansion opportunities across its card and merchant ecosystem. BUT Credit losses, funding costs, competition and regulatory changes could pressure profitability.

What matters next: Sustained growth, improving transaction economics, stable credit quality, stronger cash generation and a valuation that supports long-term upside.

Conclusion

Affirm presents an encouraging growth opportunity in digital payments and consumer finance. Its expanding merchant network, growing transaction volumes and broader product ecosystem provide a foundation for future growth. The next phase will depend on converting that scale into consistent, sustainable and risk-adjusted profitability, even during less favourable credit conditions.

For investors, the outlook remains positive if Affirm continues to strengthen its underlying economics while maintaining disciplined lending and funding practices. A careful assessment of valuation and technical trends is essential, however. Rather than chasing sharp price movements, investors may find a favourable entry through consolidation or a healthy pullback, while monitoring quarterly results for evidence that growth is translating into durable shareholder value.

Disclaimer

This report has been prepared solely for informational and educational purposes and should not be construed as investment advice or any such recommendation. Financial information is derived from publicly available company disclosures and other sources believed to be reliable; however, its accuracy and completeness are not guaranteed, and figures may be revised. Forward-looking statements, projections and estimates are subject to uncertainties and may differ materially from actual outcomes.

Readers are advised to independently verify the latest company filings, financial results, share prices, valuations and technical indicators before making any investment decisions. Investments in US- and Canadian-listed securities carry risks, including market volatility, liquidity constraints, currency fluctuations, regulatory changes and tax implications.

The author and publisher declare no affiliation with the company discussed and no personal holdings in its securities. Neither shall be held responsible for any direct or indirect loss arising from the use of, or reliance on, the information presented in this report. Investors should assess their own financial objectives, circumstances and risk tolerance and seek advice from a qualified financial professional where appropriate.

Leave a comment

Company Overview

Honeywell Aerospace supplies critical technologies for commercial aviation, business aircraft, defence and space, including avionics, navigation, power systems and flight controls.

Subscribe now

Its established aircraft presence generates recurring aftermarket revenue through maintenance, replacement parts and upgrades. The opportunity is substantial—but strong demand alone does not guarantee attractive returns.

Demand Is Strong, Profitability Is Under Pressure

Second-quarter 2026 results, reveal a mixed picture:

• Revenue: $4.522 billion, up 5% year over year.

• Net income: $256 million, versus $852 million a year earlier.

• Adjusted EBIT: $995 million, down 7%.

• Adjusted EPS: $1.87, versus $2.75.

• Order backlog: $18.154 billion, up 9%; trailing 12-month orders rose 8%.

Commercial aftermarket sales increased 8%, original-equipment sales rose 6%, and defence and space sales grew 3%.

However, management cut its 2026 organic sales growth outlook from 7–9% to 4–5% and reduced adjusted EBIT guidance from $4.65–4.75 billion to $4.35–4.45 billion. Adjusted EPS guidance was set at $7.60–7.90, while second-half free cash flow was projected at $1.0–1.5 billion.

Check Equity Reads" for Indian equities

The central concern: Customers are ordering, but supply constraints, higher costs and operational inefficiencies are preventing demand from translating into stronger profitability.

Major Growth Drivers

Commercial aviation and aftermarket: A large installed aircraft base creates recurring demand for maintenance, components and upgrades.

Defence and space: Military modernisation, navigation systems and advanced aerospace technologies offer additional opportunities.

Aircraft production: IndiGo selected Honeywell’s avionics and power systems for an order covering 810 Airbus A320neo-family aircraft. This offers long-term potential, but selection does not guarantee immediate revenues.

Technology and innovation: Upgrades focused on safety, navigation, fuel efficiency and reliability could support future growth.

Greater strategic control could help management improve production, allocate capital efficiently and strengthen margins. The real test is whether the $18.2 billion backlog can be converted into profitable sales and sustainable cash flow.

Visit "Third Publication"

Key Risks

• Supply-chain constraints: Production delays could prevent the company from meeting customer demand.

• Margin pressure: Higher costs and an unfavourable product mix could continue to erode profitability.

• Industry cyclicality: Aviation demand, aircraft production and defence procurement are sensitive to economic and policy changes.

• Execution risk: Failure to improve production, margins and cash generation could weaken the investment case despite a strong backlog.

Technical Outlook

HONA has undergone a significant correction, but the recent price action suggests that the stock may be completing a base formation after an extended decline. The narrowing moving averages and relatively stable price action near recent lows indicate a possible loss of downward momentum and the early stages of recovery.

If the stock sustains this base and buying interest strengthens, a recovery could develop into a meaningful upside move. A breakout above the immediate resistance zone, supported by stronger volumes, would provide a more convincing signal that the reversal is gaining traction.

Technical view: Early-stage recovery candidate. Watch for base confirmation, improving momentum and volume-backed breakout before drawing a stronger bullish conclusion.

Investment Thesis and Conclusion

Honeywell combines specialised technology, an established aircraft presence, recurring aftermarket demand and exposure to aviation and defence spending. Its substantial backlog offers a foundation for future growth.

Yet the reduced 2026 guidance is a clear warning: demand is not the problem; converting it into profitable growth is.

The investment case will strengthen if supply constraints ease, margins recover and free cash flow improves. Investors should distinguish the long-term business potential from the near-term risks.

Share

Overall view: Worth monitoring for operational improvement and a confirmed technical reversal. A strong backlog is encouraging, but execution, valuation and the price paid will ultimately determine shareholder returns.

Disclaimer

This report is for educational and informational purposes only and is not investment advice or a recommendation to buy or sell any security. The author does not hold shares of Honeywell Aerospace and has no affiliation with the company.

Financial information is based on publicly available company disclosures; forecasts and price scenarios are illustrative, uncertain and not guaranteed. Investors should conduct their own research and consider their risk tolerance before making investment decisions.

Leave a comment

At around US$12.75, NTLA is becoming technically interesting just as its fundamental story approaches a major regulatory event.

Positive Phase 3 data for lonvo-z and FDA acceptance of its BLA have moved the NTLA from a pure technology story toward a potential commercialisation one.

In Brief

Intellia Therapeutics is developing in-vivo CRISPR gene-editing therapies designed to address diseases at their genetic source.

Its two key programmes are:

• Lonvo-z — Hereditary Angioedema

• Nex-z — Transthyretin amyloidosis, being developed with Regeneron

The attraction is straightforward: instead of lifelong treatment, a successful therapy could potentially provide durable or even one-time disease control.

Subscribe now

Lonvo-z Changes the Investment Case

The biggest development came in April 2026, when Phase 3 HAELO data showed an 87% reduction in HAE attacks versus placebo during the six-month evaluation period.

More importantly, 62% of patients were both attack-free and free from ongoing prophylactic therapy, versus 11% for placebo. The reported safety profile was also favorable in the trial.

The next major milestone has already arrived. The FDA accepted Intellia’s BLA for lonvo-z under Priority Review, with a PDUFA action date of March 10, 2027. That makes the FDA decision the single most important near-term catalyst for NTLA.

Financial Position — the Cushion Matters

Intellia remains a loss-making development-stage biotech.

Q2 FY2026 included:

• Collaboration revenue: $7.70 million

• R&D expense: $82.60 million

• G&A expense: $37.80 million

However, the balance sheet provides some comfort. As of June 2026, the company had approximately $628.40 million in cash, cash equivalents and marketable securities, with management expecting resources to fund operations into 2028, excluding potential commercial revenue from lonvo-z. This reduces, although does not eliminate, near-term financing pressure.

What Could Drive the Next Phase?

The investment case now has four major potential drivers:

FDA approval of lonvo-z: The March 10, 2027, decision could potentially transform Intellia from a clinical-stage biotech into a commercial company.

Commercial launch: If approved, NTLA expects a US launch in 2027. A successful one-time HAE treatment could address a significant unmet need.

Nex-z / ATTR: Positive progress here would provide Intellia with a second major commercial opportunity and further validate its CRISPR platform.

Platform validation: Perhaps the biggest long-term opportunity is proving that Intellia’s in-vivo CRISPR technology can become a repeatable drug-development platform rather than a one-product story.

Visit "EquityReads" for Indian Market

What the Chart Says

The GMMA chart has improved materially from the previous breakdown, but it does not yet show a fully established Stage-2 uptrend.

After the sharp decline, NTLA formed a base and has subsequently moved into a sideways consolidation/recovery phase. The red short-term and blue longer-term moving-average groups have compressed considerably. This is important because such compression can precede a stronger directional move.

At the latest price of, however, the stock is still interacting with the GMMA cluster rather than clearly breaking above it.

Technical Interpretation

• Trend: Stabilising after a prolonged decline

• GMMA: Considerably compressed — an early sign of potential trend change

• Momentum: Improving, but not yet decisively bullish

• Volume: Recent activity is supportive, a major breakout should come with stronger volume

The key technical signal would be a sustained move above the GMMA cluster with expanding volume. That would provide stronger evidence that the stock is transitioning from accumulation into a genuine uptrend.

Chart is no longer merely recovering — it is beginning to set up for a possible trend reversal awaiting confirmation.

Risks Remain High

This remains a biotechnology investment and should not be confused with a conventional earnings-based compounder.

The principal risks are:

• Regulatory risk: Positive Phase 3 data does not guarantee FDA approval.

• Long-term safety: Permanent genetic modification carries questions around durability and off-target effects.

• Commercialisation: FDA approval would be followed by the challenge of reimbursement, physician adoption and building a revenue generating commercial organisation.

• ATTR risk: Nex-z has its own clinical and safety considerations and should not be treated as guaranteed future revenue.

  Visit "Third Publication"

Investment View

NTLA is becoming increasingly interesting for investors comfortable with high-risk biotechnology.

The combination of positive Phase 3 data, FDA Priority Review, regulatory catalyst, a substantial cash position and an improving GMMA structure creates a potentially attractive asymmetric setup.

The chart is particularly encouraging because the long decline has been followed by base formation and moving-average compression. A convincing breakout above the GMMA cluster could mark the beginning of a new technical phase.

This is still an event-driven stock. The investment thesis ultimately depends on the sequence of above events.

Our stance

For investors willing to accept substantial volatility, NTLA merits close monitoring and a positive bias. A sustained technical breakout would improve the risk-reward equation further, while failure to hold the current base would suggest patience.

Fundamentals provide the catalyst; the GMMA structure is beginning to provide confirmation; position sizing remains the key risk-control tool.

Share The Listed Edge

Disclaimer

This report is for informational and educational purposes only and should not be considered investment advice or a recommendation to buy or sell securities. Biotechnology investments can be exceptionally volatile and involve significant clinical, regulatory, financial and commercial risks.

The writer does not have any financial or other interest in NTLA, is not associated with the company in any form and has no relationship with the company or its management. The information and analysis presented above are based on publicly available information and may change as new developments occur.

Investors should conduct their own due diligence and consult a qualified financial adviser before making investment decisions.

Leave a comment

The Story Is Changing

TeraWulf is shifting from Bitcoin mining to AI, HPC and data-centre infrastructure. In Q2 2026, revenue reached $44.8 million, with 71% coming from HPC leases, versus almost none a year earlier.

The model is changing from mining Bitcoin with cheap power to securing power, building data centres, signing long-term AI/HPC leases and generating recurring revenue.

So, the key question is whether TeraWulf can turn this expansion into sustainable earnings and cash flow.

Power Is Becoming the Real Asset

TeraWulf’s emerging advantage is access to power, a critical resource for AI infrastructure. Lake Mariner already has 102 MW operational, with another 336 MW under construction.

The bigger opportunity is the 401 MW, 20-year Anthropic lease in Kentucky, worth about $19 billion over its term, with initial capacity expected in H2 2027.

TeraWulf has also secured up to 1 GW of utility capacity at its Muskie campus.

Overall, the company has indicated about 2,921 MW of potential IT capacity, including 839 MW contracted.

The strategy is becoming clear: secure power, build infrastructure and lock in long-term AI customers—potentially taking TeraWulf well beyond Bitcoin mining.

The Financial Picture Still Tells a Different Story

TeraWulf’s AI opportunity is large, but its financials remain weak.

FY2025 revenue was $168.5 million, with a $661.4 million net loss, $123.2 million operating cash outflow and $1.06 billion in capital investment.

H1 2026 revenue reached $78.8 million, including $53 million from HPC leases, but EBITDA and operating cash flow remained negative. In short, TeraWulf is spending heavily today to build a potentially much larger AI infrastructure business tomorrow.

Liquidity Helps—but Leverage and Dilution Matter

TeraWulf has substantial liquidity, but also significant financial obligations. As of June 30, 2026, it had $2.62 billion in cash and $3.03 billion including restricted cash, against about $3.02 billion of long-term debt and significant convertible notes.

The business is therefore highly capital intensive. Dilution is another concern: shares outstanding rose from about 420 million to 499 million between December 2025 and June 2026.

For investors, the key question is not simply how many megawatts or contracts TeraWulf adds, but how much sustainable cash flow and value those assets ultimately generate per share.

The Anthropic Contract Changes the Visibility

The 401 MW Anthropic agreement is a major step in TeraWulf’s transformation, providing far greater revenue visibility than its traditional Bitcoin-mining model.

But the contract is only the beginning.

Its value depends on TeraWulf’s ability to build the infrastructure, deliver the contracted capacity and manage the required financing.

The same applies to Lake Mariner and Muskie. Going forward, the market is likely to focus less on new announcements and more on converting contracted MW into operating assets, recurring revenue and cash flow.

The Biggest Risk Is Execution

TeraWulf must deliver its large projects on time and at viable costs, with Lake Mariner construction.

Large HPC contracts improve visibility but also increase customer concentration. At the same time, any slowdown in AI spending, higher financing costs or weaker data-centre economics could pressure valuations.

The Next Phase: Watch Conversion, Not Headlines

The next phase of TeraWulf’s story should be judged by execution rather than announcements.

Key markers are the commissioning of Lake Mariner’s CB-4 and CB-5, continued growth in HPC lease revenue, progress on the Anthropic project and development of Muskie’s initial 500 MW phase.

Equally important will be the company’s ability to fund expansion without excessive dilution and, ultimately, move toward positive EBITDA and sustainable operating cash flow.

The Technical Picture: An Important Zone

The stock remains in a volatile recovery phase.

With RSI around the mid-50s, the stock is neither oversold nor overbought, leaving the next directional move dependent largely on how it responds to the present levels.

Price Scenarios

These levels are scenarios, not predictions.

Over 2–6 months, a sustained move above $18.00–18.50 could shift focus toward $20–21, followed by $23–25.

Longer term, successful execution at Lake Mariner, Justified and subsequent campuses could open broader technical zones around $28–30 and potentially $35–40.

These are conditional technical and valuation scenarios—not fair-value estimates. Reaching the higher zones would require stronger earnings, cash-flow visibility and investor confidence.

The Investment Thesis Has Changed

TeraWulf’s thesis is shifting from Bitcoin mining and cheap power to AI/HPC infrastructure, long-term leases, recurring revenue and capital expansion.

The bigger opportunity is whether TeraWulf can secure power, attract long-term AI/HPC customers, finance new capacity and recycle capital for further growth.

Success could create a scalable infrastructure platform with recurring revenue, but debt, high capital needs, dilution, execution risks and AI-market uncertainty remain significant.

TeraWulf is therefore still a high-beta infrastructure growth story, not a mature data-centre business.

What Matters from Here

TeraWulf remains between key support and resistance levels, with the chart still in a recovery phase. The bigger trigger, however, is whether its contracted capacity converts into recurring revenue, positive EBITDA and sustainable cash flow.

TeraWulf is no longer primarily a Bitcoin story; it is increasingly a bet on whether its power advantage can support a durable AI-infrastructure business, while execution and financing risks remain significant.

Disclaimer:

This report is for research and educational purposes only and is not investment advice or a buy/sell recommendation. Technical levels are scenarios, not predictions. Financial information is based primarily on company filings and disclosures, while technical observations use market data through September 23, 2026.

TeraWulf is highly volatile and capital-intensive, with significant execution, financing, dilution, interest-rate, customer-concentration and AI-market risks. Readers should verify the latest company disclosures and market data before making investment decisions.

The writer holds no shares or securities of TeraWulf Inc and has no financial interest in the company.

Imagine being right on only slightly more than half your trades—and still building an extraordinary investment record.

That was the idea behind Jim Simons and Renaissance Technologies. A mathematician and codebreaker, Simons used mathematics and data to search for small, repeatable market patterns rather than relying mainly on forecasts or intuition.

The key lesson is simple: a small, genuine edge, applied consistently with discipline, can become remarkably powerful.

From Mathematics to Markets

Jim Simons was a distinguished mathematician long before entering finance. He earned his PhD from UC Berkeley, worked as a codebreaker and later chaired mathematics at Stony Brook University. His work with Shiing-Shen Chern influenced modern mathematics and physics.

Around 40, Simons turned to financial markets, asking whether mathematics and data could uncover repeatable market patterns.

This led to Renaissance Technologies, where he brought together mathematicians, physicists, statisticians and computer scientists—many without traditional trading backgrounds.

The core idea was simple: replace intuition-driven investing with data, patterns and systematic strategies.

The Medallion Fund: An Extraordinary Record

Launched in 1988, the Medallion Fund became Jim Simons’ most famous investment operation.

From 1988–2018, it reportedly delivered about 66.10% annual returns before fees and 39.10% after fees. During the 2008 crisis, it reportedly gained more than 80% after fees, while the S&P 500 fell about 38%.

However, Medallion is a private fund and does not publish audited results comparable with public investment companies. Its capacity was also deliberately limited, with profits distributed to investors.

The key takeaway is not to expect similar returns, but that Renaissance appears to have built a persistent quantitative edge and applied it with extraordinary discipline.

How Simons Compares with the Investment Greats

The reported 39.10% annual return after fees for Medallion is often compared with approximately 32% for George Soros’ Quantum Fund, 29% for Peter Lynch’s Magellan Fund, and 20.50% for Warren Buffett’s Berkshire Hathaway over their respective periods. The broader lesson is that extraordinary results can come from very different investment processes.

The Renaissance Approach

Renaissance Technologies did not rely on one magic formula. It analyzed vast amounts of market data and used multiple models and signals across stocks, futures, currencies, commodities and bonds.

Data quality was critical, while hundreds or thousands of models could operate simultaneously.

The philosophy was simple: combine many small, repeatable opportunities rather than depend on one big prediction.

Simons’ model-driven approach also reduced emotional interference—an idea investors can apply more broadly: rules created with a calm mind can protect against emotional decisions during stressful markets.

The Power of a Small Edge

Perhaps Simons’ most important lesson is the power of repetition.

An investor does not need to be right 70% or 80% of the time. A small, genuine edge, repeated consistently, can become meaningful over many trades.

The exact 50.75% example is less important than the principle. Real markets involve different trade sizes, costs, taxes, slippage and changing conditions—and past success may not continue.

The key lesson is simple:

A small advantage becomes valuable only when it is real, measurable and repeatable.

Evidence Over Intuition

Simons’ philosophy challenges investors to value evidence over stories.

A company may have strong management, a growing industry or a large market opportunity—but a compelling story does not necessarily prove an investment edge.

The better question is:

When similar conditions occurred in the past, what happened next?

Technical indicators, momentum, breakouts and other setups can be treated as hypotheses and tested for frequency of success, average outcomes, drawdowns and performance across different market conditions.

The key shift is from prediction to measurement—turning market opinions into evidence that can be analysed.

What Indian Investors Can Learn

Individual investors cannot replicate Renaissance Technologies, but they can adopt some of its principles.

Start with a clearly defined, repeatable setup using factors such as price structure, momentum, RSI, moving averages, GMMA or Stage Analysis. Turn the idea into rules rather than relying on “I like this stock.”

Then test the setup historically, examining the success rates, returns, drawdowns and performance across different market conditions.

Before committing capital, define the entry, invalidation level, position size and profit-taking rules.

The goal is not to replicate Renaissance, but to bring discipline, measurement and consistency into investing.

The Limits of the Simons Approach

Quantitative investing has an important limitation: historical data can create false confidence. A strategy may look excellent in back-tests simply because it has been over-optimized for the past—a problem known as overfitting.

Renaissance also had enormous datasets, advanced technology and specialized researchers, while retail investors face costs, taxes, slippage and execution constraints.

The goal, therefore, is not to recreate Medallion, but to adopt its discipline:

Measure, test, control risk and change when the evidence changes.

The Bigger Investment Lesson

Jim Simons’ greatest contribution may have been a different way of thinking about uncertainty.

Instead of asking “What will happen to this stock?”, the Simons approach asks:

“When these conditions occurred before, what happened next—and how consistently?”

Whether fundamental, technical or long-term, investors can apply the same principles:

Define the process. Measure results. Control risk. Avoid emotional decisions. Keep learning. Question your assumptions.

The Bottom Line

Jim Simons’ story is about more than mathematics—it is about finding an edge and testing whether it is real. The reported Medallion results are extraordinary, but their private, capacity-constrained structure and methodological limitations warrant caution.

Investors can adopt the Simons mindset by putting data over opinion, evidence over stories, probabilities over predictions, rules over emotions, many small edges over one big bet, and continuous testing and improvement.

You may never have Renaissance’s resources, but you can test ideas, measure results, control risk and question assumptions.

The enduring lesson is simple: replace “I think” with “What does the evidence show?”

Disclaimer

This report is for educational and informational purposes only and is not investment, financial or research advice, nor a recommendation to buy, sell or hold any security.

A COMPANY IN TRANSITION

CleanSpark, Inc. is evolving from a Bitcoin miner into a broader digital-infrastructure company, combining Bitcoin mining with the development of infrastructure for AI and high-performance computing.

The company reports more than 1.8 GW of power, land and data-centre infrastructure across the US. This power and infrastructure portfolio could become increasingly valuable as demand for AI/HPC capacity grows.

The key development is the Sandersville project, where CleanSpark has signed a 20-year triple-net lease expected to generate approximately $6.6 billion in contracted revenue. If successfully executed, Sandersville could mark an important shift in CleanSpark’s revenue mix—from the volatility of Bitcoin mining toward long-duration, contracted digital-infra revenues.

FINANCIAL PICTURE

CleanSpark has achieved significant scale, but its financial performance remains volatile.

FY2025 revenue rose 102.2% to $766.3 million, with net income of $364.5 million.

FY2026 has been more challenging.

Q3 revenue fell 30.5% YoY to $138 million, while the company reported a $239.8 million net loss. Revenue for the first nine months was approximately $455.6 million.

The Balance Sheet also warrants attention. As of June 2026, CleanSpark held $202.6 million in cash and $814.9 million in Bitcoin, against $1.8 billion of long-term debt and total assets of $2.7 billion.

The financial thesis therefore goes beyond revenue growth: CleanSpark must convert its power and infra-assets into durable contracted cash flows while managing the higher leverage required funding that expansion.

GROWTH DRIVERS

CleanSpark is expanding beyond Bitcoin mining into AI and high-performance computing infrastructure.

It has 1.8 GW of contracted power capacity, with 808 MW utilized as of August 2026. Its key advantage increasingly lies in the combination of power, land, grid access and infrastructure.

Bitcoin remains a significant operating driver. A stronger Bitcoin environment could support higher mining revenue, earnings and cash flow.

The $6.6 billion of contracted revenue associated with Sandersville could become a major long-term catalyst.

KEY RISK FACTORS

Bitcoin mining remains cyclical. Lower Bitcoin prices, rising network difficulty or higher energy costs can quickly pressure mining margins.

Leverage is a key risk. CleanSpark had approximately $1.8 billion of long-term debt and subsequently priced another $2.276 billions of secured notes for the Sandersville project. While the financing supports contracted infrastructure, it also increases financial obligations and execution pressure.

CleanSpark’s transition from Bitcoin mining to digital infrastructure is still underway. The thesis depends on successfully completing projects and converting planned capacity into the expected revenues and cash flows.

AI/HPC infrastructure requires substantial capital. Cost overruns, construction delays, power constraints or financing conditions could affect project economics and returns.

READING THE CHART

The chart uses the Guppy Multiple Moving Average and shows a notable change in the stock’s technical structure.

The key development is the recent reversal from the lower base. The stock has moved above the compressed moving-average structure and trading above the entire Guppy ribbon.

The chart also shows the short-term red averages turning upward, while the longer-term blue averages are beginning to flatten and turn higher. This represents a clear improvement from the earlier bearish structure.

The most encouraging feature is not simply the recent price rise, but the change in the moving-average structure. The short-term averages have moved above the longer-term cluster, while the longer-term averages are beginning to turn upward. This suggests the stock may be entering a new trending phase rather than merely experiencing a short-lived rebound.

From a technical perspective, improving GMMA structure is encouraging, but confirmation through sustained price action remains important.

IMPORTANT TECHNICAL LEVELS

Based on the chart and the current price structure, three levels stand out.

Immediate Support: $13.0–$13.5: This is the first support zone to watch during a normal pullback.

Resistance: $16–$17: A decisive move above this area, supported by expanding volume, would provide further technical confirmation of the developing uptrend.

TECHNICAL TARGETS

Short Term: $16.5–$17.5: The immediate technical zone is $16.5–$17.5. A period of consolidation or a controlled pullback toward support would be healthier than a sharp vertical rise. A decisive breakout above $17.5 could signal the next leg higher.

Medium Term: $19–$21: If CLSK holds above $17.5 and the Guppy averages continue expanding upward, the next technical zone is $19–$21, near the upper end of its recent trading range.

Long Term: $23–$25: A sustained breakout could eventually bring $23–$25 into focus. This remains a chart-based target, not a fundamental valuation estimate, and the zone could offer significant resistance given the stock’s previous highs.

INVESTMENT THESIS

CleanSpark combines Bitcoin exposure, large-scale power infrastructure and an emerging AI/HPC data-centre opportunity.

The longer-term thesis increasingly extends beyond Bitcoin mining: the potential to convert its power and data-centre assets into durable, contracted infrastructure revenue could materially change the business profile. The Sandersville agreement is an important step in that direction.

At the same time, the transition involves substantial execution, capital-allocation and financial risks. The key question is whether CleanSpark can convert its infrastructure portfolio into sustainable AI/HPC cash flows quickly enough to justify the capital being deployed.

You can share your views.

DISCLAIMER: These are the technical and fundamental views only and not a buy/sell recommendation.

The price targets and support/resistance levels presented in this report are chart-based reference levels derived from the chart and technical analysis and should not be interpreted as forecasts or guarantees of future performance.

CleanSpark remains exposed to significant risks, including Bitcoin-price volatility, mining economics, leverage, financing requirements, construction and execution risks, tenant-related risks and regulatory developments. Investors should therefore conduct their own research and consider their individual risk tolerance before making any investment decision.

Kristjan Kullamägi, better known as Qullamaggie, did not begin his trading career from a conventional financial background. Born in Sweden, he was studying biomedical laboratory science in his early twenties while working part-time as a security guard, including a stint at the Nasdaq Stockholm building. His exposure to the people and businesses connected with the markets gradually developed into an interest in trading.

In 2011, at around 23, he began trading U.S. stocks with approximately US$5,000 of savings. The early years were difficult. He followed online day traders, lacked a defined system and proper risk management, and blew up several small accounts. After each setback, he returned to his security job, saved money and continued studying charts and successful traders.

He eventually left his degree in its final months to concentrate fully on trading. By 2013, he had his first profitable year and gradually moved from day trading towards swing trading. His subsequent journey involved thousands of hours studying charts, market leaders and historical setups before he developed the focused framework for which he is now known.

Three Setups at the Core

Kullamägi’s methodology is centred around three broad setups:

1. Breakouts

2. Episodic Pivots (EPs)

3. Parabolic Shorts

The philosophy is relatively simple:

Find exceptional stocks → wait for a specific structure → enter when momentum confirms → control risk → allow strong winners to run.

Breakouts: Strength Before the Break

Kullamägi generally looks for stocks that have already demonstrated leadership through strong 1-month, 3-month and 6-month performance.

A typical pattern is:

Strong advance → consolidation → renewed expansion

The consolidation matters. He looks for higher lows, tightening price action, declining volatility and support around the 10-day and 20-day moving averages, followed by decisive price and volume expansion.

The idea is not simply to buy because resistance has been crossed. The bigger question is:

Has a strong stock consolidated constructively before attempting another expansion?

Episodic Pivot: When Expectations Change

An Episodic Pivot occurs when new information suddenly changes the market’s perception of a company.

Examples include exceptional earnings, major guidance changes, FDA developments, large contracts or unexpected corporate developments. These events can produce a significant price gap accompanied by exceptional volume.

Kullamägi has particularly studied EPs in stocks that had previously spent 3–6 months or more moving sideways. More importantly, he studied thousands of historical examples before becoming confident in the setup.

Parabolic Shorts: Waiting for the Turn

The third setup is effectively the opposite of a breakout:

Extreme acceleration → excessive extension → failure/reversal

But being overbought is not enough.

The reversal has to begin.

Kullamägi has acknowledged that some of his largest losses came from short positions, including losses involving TVIX and KODK.

The lesson is important: extreme strength does not automatically mean an immediate reversal.

Risk Management Comes First

Perhaps the most transferable part of his approach is risk management.

Kullamägi has described typical positions of around 10–20% of account value, while generally risking only around 0.25–1% of total account equity per trade.

The distinction is crucial:

Position size ≠ risk.

For example, on a ₹10 lakh account, a ₹2 lakh position with a 4% stop represents a planned loss of ₹8,000—or only 0.8% of the account.

The objective is not to avoid losses. It is to ensure that one loss does not damage the ability to participate in the next opportunity.

Moving Averages as Trend Tools

The 10-day and 20-day moving averages are important in Kullamägi’s framework, but not primarily as crossover signals.

They are used to understand trend behaviour and manage positions.

A strong stock may:

Run → pull back → find support near the 10/20 DMA → resume higher.

The averages therefore provide trend context and trade-management references, rather than acting as a standalone strategy.

Study Thousands of Charts

One of the strongest lessons from Kullamägi’s methodology is the importance of historical study. He advocates examining thousands of examples, including successful and failed breakouts, EPs, parabolic reversals, volume behaviour, consolidation, entries, stops and follow-through.

This is how a trader develops pattern recognition rather than simply memorising setups.

A Losing Trade Can Still Be a Good Trade

Kullamägi makes an important distinction between trade outcome and trade quality. A losing trade can still be a good trade if the setup was valid, risk was controlled and the process was followed.

Likewise, a profitable trade can be a poor trade if it violated the trading plan.

For technical traders, the lesson is simple:

Judge the process first; the outcome comes later.

The EquityReads Takeaway

Kullamägi’s story is ultimately less about the headline “$3,000 to $100 million” and more about the process that came before it.

Repeated failures led to deeper study. Study led to specialization. Specialization led to a focused playbook.

His framework reminds technical traders that a breakout is not simply a price crossing resistance.

It is about leadership, momentum, structure, volume, market conditions and risk.

And perhaps the biggest lesson is simple:

The objective is not to predict every market move. It is to develop a repeatable process that allows you to participate when the right opportunity appears.

The next logical step is to adapt this framework to Indian equities through relative-strength screening, momentum filters, 10/20/50 DMA structure, breakout volume, catalyst-driven setups, reversal patterns, position sizing and market-regime filters.

Disclaimer

Technical view only; not a buy/sell recommendation

This article is intended for educational and informational purposes only. The performance figures associated with Kristjan Kullamägi are self-reported and are not presented as independently audited investment returns. Past trading performance does not guarantee future results. Readers should conduct their own research and consider their individual risk tolerance before making any investment or trading decision.

MDA Space combines a strong, strategically positioned space-tech business with a chart still awaiting a confirmed long-term reversal.

Its growth exposure spans satellites, LEO constellations, robotics, defence, geointelligence, Earth observation and next-gen space communications, supported by platforms such as AURORA, SKYMAKER and CHORUS and strengthened by the SatixFy acquisition.

The business is strong. The key question now is whether the stock can translate that strength into a sustainable technical uptrend.

The Fundamental Story Remains Strong

MDA Space delivered record FY2025 revenue up 51% YoY and adjusted net income jumped 71%.

The growth is backed by strong visibility, with C$4 billion of backlog and an approximately C$40 billion opportunity pipeline, including around C$10 billion of government opportunities.

Q2 FY2026 strengthened the story: revenue rose 34% YoY, adjusted EBITDA increased 26% and backlog remained around C$4 billion. Management also raised its 2026 revenue guidance to C$1.85 billion, with adjusted EBITDA guidance of C$330–370 million.

This is therefore far more than a speculative space play. MDA already has established satellite-manufacturing, robotics, geointelligence and defence capabilities, supported by significant customers and a substantial order book.

Satellite Systems Could Remain a Major Growth Engine

MDA’s Satellite Systems division is a major growth driver. FY2025 revenue reached approximately up 85.5%, driven largely by the Telesat Lightspeed and Globalstar next-generation LEO constellation programmes.

This positions MDA at the long-term space-industry themes including satellite communications, LEO constellations, robotics, Earth observation and defence. Importantly, MDA is pursuing these opportunities from an established industrial base with proven capabilities and customers, rather than simply betting on future technologies.

The One Fundamental Area to Watch: Cash Flow

The balance sheet remains comfortable, with FY2025 operating cash flow of C$407 million, free cash flow of C$165 million and net debt/adjusted EBITDA at just 0.4x.

However, MDA is investing heavily in capacity expansion and chip development, with 2026 capex guided at C$225–275 million.

Management expects free cash flow to be neutral to negative as investment and working-capital needs rise. This is manageable for a growth company but sustained revenue and EBITDA growth must ultimately translate into stronger cash generation.

The Chart Tells a Different Story

This is where MDA becomes particularly interesting. Fundamentals remain strong, but the technical structure is still weak.

After a powerful earlier advance, the stock entered a prolonged correction and distribution phase, forming a familiar pattern:

Peak → lower highs → lower lows → weakening averages → failed rebounds → renewed selling.

The Guppy Multiple Moving Average clearly reflects this shift. The earlier separation between short- and long-term averages has given way to compression and a bearish structure. Short-term averages remain below the longer-term group, while the latter continue to slope downward.

The message is clear: the chart has not yet confirmed a major long-term reversal.

C$39–40: The Immediate Battleground

The most important technical feature is the C$39–40 support zone.

With the stock around the C$40 area, this region has become an important decision point. If buyers continue to defend it, the stock could attempt a recovery. But holding C$40 alone should not be interpreted as confirmation of a new bull trend.

The technical roadmap is relatively straightforward:

C$39–40 — immediate support

C$37–38 — next support if C$39–40 fails

C$34–35 — stronger medium-term support

A decisive close below C$39 would weaken the immediate recovery setup, while a breakdown below C$37, particularly with expanding volume, would indicate that the current base may have failed.

Short-, Medium- & Long-Term View

Short Term: If C$39–40 holds, MDA could move toward C$42–43, followed by C$45–46 and on a strong breakout, C$48–50. However, sustained closes above resistance with improving volume are essential.

Medium Term: A convincing move above C$45 and reclaim of C$47–50 would strengthen the setup, opening C$52–55 and then C$58–60. A sustained move above C$60 would signal a much stronger recovery.

Long Term: If the stock completes the sequence C$39–40 base → C$45 → C$50 → C$55–60, higher zones of C$65–68 and C$72–75 could come into play, with C$80+ possible in a strong space-and-defence cycle.

These are conditional targets, not immediate expectations. The first requirement is confirmation that the current downtrend has ended.

The Listed Edge View

MDA Space is a case where the business appears ahead of the chart. Strong growth, a C$4 billion backlog and exposure to satellites, LEO constellations, robotics, geointelligence and defence support the fundamental story.

Technically, however, MDA is crossing the decision point around C$39–40. A move above C$42–45, would strengthen the recovery case and bring the higher levels into focus.

In simple terms:

MDA is a fundamentally strong space-tech company sitting at a technically important base. It is therefore a stock worth monitoring rather than chasing.

Disclaimer

Technical view only; not a buy/sell recommendation

This article is for educational and informational purposes only and represents an analytical view based on the company’s reported financial information and the technical chart. Price targets and support/resistance levels are technical estimates, not guarantees or investment recommendations. MDA Space is a volatile aerospace and space-technology stock, and valuation, execution, contracts, capital expenditure, cash flow and broader market conditions can materially affect its share price. Investors should conduct their own research and consult a qualified financial adviser before making investment decisions.

Explore our research notes and investing frameworks and subscribe to Equity Reads for in-depth market insights. If you enjoy broader perspectives on markets, businesses, subscribe to TheListedEdge as well.

You can also visit Third Publication for thoughtful perspectives on geopolitics, strategic affairs and the forces shaping the global economy.

At around C$25.50, 5N Plus stands out as a Canadian specialty-materials company with growing exposure to solar, space, semiconductors and defence. Following a significant correction, the stock is at an interesting point where improving fundamentals could eventually support a technical turnaround.

Company Overview

5N Plus has evolved into a global supplier of high-purity semiconductor and advanced materials. Its acquisition of AZUR SPACE Solar Power further strengthened its position in high-efficiency solar cells used in satellites and other demanding applications. The company operates through two main segments—Specialty Semiconductors and Performance Materials—with operations across North America, Europe and Asia.

Strong H1 2026 Performance

The financial picture is increasingly compelling. H1 2026 revenue reached US$240.3 million, while Adjusted EBITDA rose to US$55.8 million.

Balance-sheet strength has also improved significantly, with net debt falling to just US$23.70 million and net debt/EBITDA at only 0.21x.

Management maintained its 2026 Adjusted EBITDA guidance of US$100–105 million, while the company’s US$420 million backlog, equivalent to roughly 313 days of annualized revenue, provides substantial visibility into future business.

Strategic Catalysts

5N Plus is benefiting from several powerful structural trends:

• Solar: Growing demand for advanced semiconductor materials used in photovoltaic applications.

• Space: High-efficiency solar cells for satellites and space systems.

• Defence: A US$7.30 million U.S. government award supports domestic production of gallium-arsenide components for defence applications.

• Critical materials: Exposure to strategically important materials including gallium, germanium, tellurium and bismuth.

• Capacity expansion: New capacity, particularly in space solar, could allow the company to convert its strong backlog and demand into further revenue and EBITDA growth.

Together, these factors position 5N Plus within several strategic and supply-chain-sensitive markets where security of supply is becoming increasingly important.

Key Risks

The principal risks include commodity-price volatility, customer concentration, margin fluctuations and execution risk related to capacity expansion. Most importantly, the strong fundamental story has not yet translated into a confirmed technical uptrend.

Technical Setup & Price Targets

The Guppy chart continues to show VNP below its moving-average ribbon, indicating that the primary trend remains bearish. However, the C$24.50–25 area is emerging as an important potential support zone.

• C$24.50–25: Key support / accumulation zone

• C$27.50–30: Initial recovery zone

• C$32–35: Medium-term breakout target

• C$38–42: Longer-term target if earnings momentum continues

A sustained move above C$30–32, preferably accompanied by stronger volume, would provide the first meaningful confirmation that the longer-term trend is turning positive.

Investment Thesis

The attraction of 5N Plus lies in the combination of strong earnings growth, a substantial backlog, very low leverage and exposure to multiple long-term growth themes.

The stock is currently caught between improving fundamentals and a still-bearish technical trend. At around C$25.50, this makes VNP more of a turnaround opportunity to monitor than a confirmed technical breakout.

If management continues converting its backlog into revenue and EBITDA, the fundamental case could strengthen considerably.

Bottom Line

5N Plus offers an intriguing medium- to long-term growth and turnaround story. Its strong backlog, improving earnings, low leverage and strategic exposure to solar, space and defence provide a solid fundamental foundation. The major question is whether the improving business momentum can finally trigger a sustained technical reversal.

Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors should conduct their own research and consider their risk tolerance before making investment decisions.

Upstart is increasingly becoming a turnaround-plus-growth story, combining AI-driven lending with rapidly improving revenue, originations and profitability. The key question now is whether this growth can remain sustainable through the credit cycle—and ultimately support a durable rerating of the stock.

The Fundamental Picture

Upstart operates an AI-powered lending marketplace connecting consumers with banks, credit unions and institutional investors. Its AI underwriting platform automates more than 90% of loans.

The financial recovery has been significant:

• FY2025 revenue: ~$1.0 billion, +64% YoY

• Loan Originations: ~$11 billion, +86%

• Net profit: $53.6 million vs. a $129 million loss in 2024

• Q2 2026 revenue: $365 million, +42% YoY

• Q2 originations: $4.2 billion, +50%

• Q2 adjusted EBITDA: $76.9 million, 21% margin

Management targets approximately $1.4 billion revenue and $294 million adjusted EBITDA for FY2026, with roughly 35% revenue CAGR through 2028.

The key takeaway: Upstart is increasingly moving beyond being an “AI growth story” and demonstrating growth alongside improving profitability.

Technical Outlook

At around $29, UPST remains in a consolidation phase following its earlier decline. Price action is showing signs of stabilization around $28–30, while the Guppy Multiple Moving Averages (GMMA) indicate that the stock is approaching an important decision zone.

• $28: Key support and downside pivot

• $28–32: Primary consolidation and breakout zone

• $31.5–32: Major resistance

• Above $32 with strong volume: Bullish confirmation

The key technical trigger is therefore a decisive, volume-backed breakout above $31.50–32. A sustained move above this zone could signal the end of the consolidation phase and potentially initiate a stronger medium-term uptrend.

Potential Price Scenarios

Short term — $31.50–33: The first upside objective following a successful breakout above resistance.

Bullish extension — $35–38: Potential next target if UPST breaks above $32 and maintains positive momentum.

Medium term — $40–45: A significant recovery zone that would require sustained buying interest and improving fundamentals.

Medium/long term — $50–60: Achievable only if earnings growth continues to strengthen and investor sentiment remains supportive.

Bull case — $65–75+: A higher-end scenario requiring sustained high growth, strong operating performance and a meaningful valuation rerating.

These levels represent technical and scenario-based price objectives, not guaranteed forecasts. Actual outcomes will depend on earnings, market conditions, valuation and investor sentiment.

What Could Drive the Next Leg of Growth?

AI underwriting and new products: Upstart’s proprietary models use thousands of variables and a large repayment dataset. Continued model improvement, alongside products such as Cash Line, HELOCs and other lending products, could strengthen its technology advantage and diversify revenue beyond personal loans.

Auto and Home: These businesses are scaling rapidly, with Q2 2026 Auto originations up 264% YoY and Home originations up 139%. Their ability to scale while reaching sustainable profitability will be important.

Upstart Bank: The OCC granted conditional approval in July 2026, with management targeting an early-2027 launch, subject to remaining regulatory steps. The bank could broaden product availability and simplify aspects of the business model.

Institutional funding: Funding remains critical to Upstart’s marketplace. The $4 billion multi-year forward-flow agreement with Castlelake, along with other commitments, could provide greater visibility for future originations.

Key Risks

• Credit cycle: Upstart’s Macro Index was 1.50 in August 2026, indicating estimated macro-driven default risk remained roughly 50% above its normal baseline.

• Funding: The business depends heavily on banks and institutional investors funding or purchasing loans.

• Auto & Home profitability: Despite rapid growth, combined contribution margin remained negative 35% in Q2 2026.

• Volatility: UPST can trade like a high-beta technology stock, making sharp corrections possible even after strong results.

• Regulation & competition: The bank approval remains conditional, while banks, fintechs and other AI-lending platforms continue to compete aggressively.

My Take

Upstart is becoming a more compelling turnaround-plus-growth candidate. Revenue, originations and profitability are moving in the right direction, with Q2 2026 delivering 42% revenue growth and 50% origination growth.

However, the technical picture still requires confirmation. At around $29, the stock remains within its consolidation range, making $31.50–32 the key trigger.

A volume-backed breakout above $32 could open the way toward $35–38 initially and $40–45 thereafter. Conversely, a sustained break below $27–28 would materially weaken the setup.

For investors comfortable with high volatility, the $28–30 zone offers an interesting risk/reward area, provided the fundamental story remains intact.

Bottom Line

UPST is evolving from an AI story into an AI-enabled lending platform showing real operating leverage.

The fundamentals are improving, but the chart still needs confirmation.

$32 is the level to watch. A decisive breakout could signal the next leg of the recovery, while failure to hold $28 would keep the stock in a defensive setup.

Disclaimer

This report is intended solely for educational and informational purposes and should not be considered investment advice, a recommendation, or a solicitation to buy or sell any security. The price targets and scenarios discussed are analytical estimates based on the supplied technical chart and fundamental information and are not guaranteed forecasts. Investors should conduct their own research and consider their investment horizon, risk tolerance and financial circumstances before making any investment decision.

This version is structured more like a Substack investment research article—stronger opening hook, clearer investment thesis, scannable sections, and a sharper “Bottom Line” while preserving the source report’s core analysis and targets.

Bet on the Nuclear Renaissance

NuScale Power offers direct exposure to the emerging Small Modular Reactor (SMR) industry, supported by rising AI/data-centre power demand, energy security and global decarbonization.

Its key advantage is its NRC-approved 77 MWe SMR design, with modular configurations scalable up to 12 modules or 924 MWe. Potential applications include utilities, data centres, industrial facilities, hydrogen, desalination and district heating.

NuScale’s opportunity extends beyond reactor sales, with potential revenue from licensing, engineering, project development and long-term operations & maintenance.

The opportunity is significant, but so is the risk. NuScale remains a commercialization-stage company, making the conversion of its technology into funded projects and sustainable revenues the key determinant of its long-term valuation.

Technology Advantage: NRC Approval

NuScale’s 77-MWe reactor received NRC approval in May 2025, making it one of the first advanced SMR designs licensed by the world’s leading nuclear regulator.

Why it matters

• Validates safety and reactor design.

• Reduces regulatory uncertainty for customers.

• Creates a meaningful barrier to entry.

• Gives NuScale a first-mover advantage in commercial SMRs.

Financial Snapshot

NuScale’s balance sheet is one of its biggest strengths, with approximately $1.9 billion in cash, cash equivalents, and investments and zero debt, giving it ample financial runway for commercialization. However, its operating performance remains weak: FY2025 revenue declined to $31.5 million (from $37 million in FY2024), H1 2026 revenue was just $640,000, and the company reported a $96.7 million net loss in the first half of 2026. The key takeaway is clear: NuScale is financially well-funded, but meaningful commercial revenue has yet to materialize as it continues investing heavily in bringing its SMR technology to market.

NuScale Power — Key Growth Drivers

Commercial SMR Deployment: Funded SMR projects could transform NuScale from a technology company into a revenue-generating nuclear infrastructure company.

TVA Partnership: A commercial agreement with the Tennessee Valley Authority (TVA) would provide significant validation of NuScale’s technology and commercial potential.

Romania — RoPower Project: The six-module RoPower project could become NuScale’s first major international reference plant and strengthen its position in Europe.

AI & Data Centres: Rising electricity demand from AI and data centres creates a potentially large long-term market for reliable, around-the-clock nuclear power.

Supply-Chain Readiness: With 60+ supplier partnerships, NuScale has built a growing ecosystem to support manufacturing and future SMR deployment.

Bottom Line: The major catalyst is the transition from SMR technology development to funded commercial projects and actual revenue generation.

Why the SMR Theme Matters

Four structural trends are driving long-term interest in SMRs:

• Energy Security: Reliable domestic electricity.

• Decarbonization: Carbon-free baseload power alongside renewables.

• AI Infrastructure: Massive electricity demand from data centres.

• Industrial Electrification: Clean power for hydrogen, desalination and manufacturing.

NuScale Power — Key Risks

Commercialization: NRC approval is an important milestone, but it does not guarantee reactor orders or revenue.

Weak Revenue: Current revenue remains small compared with operating losses, reflecting NuScale’s early commercial stage.

Cash Burn: Heavy investment continues while the company awaits meaningful commercial revenues.

Bottom Line: NuScale’s biggest challenge is converting regulatory and technological progress into funded projects, revenue and sustainable cash flow.

NuScale Power — Technical Price Levels

$8–10 — Accumulation Zone: A potential long-term accumulation zone, subject to overall market conditions and company execution.

$10.20–10.70 — First Resistance: The first important resistance area. A sustained move above this zone would improve the technical setup.

$11.00–11.70 — Major Breakout Zone: A decisive breakout above this range could signal a stronger medium-term recovery.

$13–15 — Medium-Term Target: Potential target zone following a successful breakout above the major resistance.

$17–18 — Extended Target: An extended recovery target if the breakout sustains momentum.

$20–25 — Long-Term Bull Case: A potential long-term target range if commercialization succeeds and NuScale converts its technology pipeline into meaningful projects and revenues.

Final Conclusion

NuScale offers direct exposure to one of the most compelling long-term energy themes: Small Modular Nuclear Reactors. Its strengths are a licensed reactor design, a debt-free balance sheet, and exposure to AI-driven electricity demand—make it an attractive long-term story. However, until commercial reactor projects begin generating recurring revenue, it may be viewed as a speculative satellite position also.

Investor takeaway: The opportunity is real, but commercialization—not technology—is the milestone that will determine NuScale’s future valuation.

Disclaimer

This report is intended solely for educational and informational purposes and should not be construed as investment advice, a recommendation, or a solicitation to buy or sell any security. The price scenarios and technical levels discussed are analytical estimates based on the available data, chart and potential business outcomes; they are not guaranteed forecasts. NuScale Power remains a highly speculative company with significant commercialization, execution, financing, dilution, construction, and regulatory risks. Investors should conduct their own due diligence and consider their financial position, investment objectives, and risk tolerance before making any investment decision.

For more than a century, International Business Machines Corporation (NYSE: IBM) has reinvented itself repeatedly—from punch-card machines to mainframes, from IT services to hybrid cloud, and now to Artificial Intelligence.

While the stock has corrected from its recent highs, the long-term investment thesis remains centered on its transformation into an AI-driven enterprise software company rather than a traditional hardware business.

Why Did IBM’s Share Price Correct?

IBM’s recent correction was driven largely by market dynamics rather than any significant deterioration in its underlying business. After a strong rally, investors booked profits, while the stock’s higher valuation made a period of consolidation both expected and healthy.

The decline was also influenced by a temporary slowdown in consulting demand, the cyclical nature of its infrastructure business, and a broader market rotation towards faster-growing AI-focused companies.

Overall, the correction appears to reflect profit booking, valuation adjustment and sector rotation, rather than any fundamental weakness, and may represent a healthy pause in IBM’s long-term transformation story.

Business Overview

IBM has transformed itself from a traditional hardware manufacturer into a leading enterprise technology company with four core business segments.

Its Software business is the primary growth engine, driven by Red Hat, hybrid cloud, automation, cybersecurity and data platforms, while Consulting supports enterprises in digital transformation, cloud migration and AI adoption. The Infrastructure division continues to provide mission-critical mainframe and storage solutions to large enterprises and governments, and the Financing segment strengthens customer relationships by offering flexible technology financing.

Together, these businesses provide IBM with a balanced mix of recurring software revenues, consulting expertise and stable infra income, supporting its long-term growth strategy.

AI Strategy

IBM has adopted an enterprise-first AI strategy, focusing on secure and scalable AI solutions for highly regulated industries such as banking, healthcare, government and insurance, rather than competing in consumer AI.

Its watsonx platform, integrated with Red Hat OpenShift, enables organisations to build, deploy and manage AI applications across both on-premises and public cloud environments.

Financial Strength

IBM has strengthened its financial position by shifting towards higher-margin SW and AI-driven businesses, supported by recurring revenues and strong cash generation.

Key Strengths

IBM benefits from healthy free cash flow, improving operating margins, an investment-grade balance sheet and a long history of dividend payments. Growing AI-related bookings further indicate that its strategic transformation is gaining momentum and supporting future growth.

Key Areas to Watch

Investors should continue to monitor consulting demand, the cyclical nature of the mainframe business, progress in debt reduction and, most importantly, IBM’s ability to sustain software growth and successfully monetize its AI initiatives. These factors will play a crucial role in shaping the company’s long-term earnings trajectory.

Growth Drivers

IBM’s future growth is expected to be driven by the accelerating adoption of enterprise AI and hybrid cloud computing. The continued expansion of watsonx platform, growth of Red Hat ecosystem and rising demand for cybersecurity and automation solutions are likely to support higher recurring revenues. Looking ahead, IBM’s leadership in quantum computing offers an additional long-term growth opportunity, while its robust FCF should continue supporting dividend growth, strategic investments and shareholder return through share repurchases.

Investment View

IBM offers a balanced investment opportunity, combining the resilience of a Mature Tech company with long-term growth drivers such as enterprise AI, hybrid cloud and mission-critical software. While recent correction moderated near-term momentum, its improving fundamentals and technical setup continue to support a constructive outlook across all investment horizons.

Short-Term Outlook - Neutral to Positive

The stock appears to be emerging from its correction and entering a base-building phase. Although institutional buying is yet to be fully confirmed, improving short-term momentum suggests that sentiment is gradually turning positive. A decisive breakout above the long-term Guppy Moving Averages, supported by stronger volumes, would strengthen the bullish case.

Medium-Term Outlook - Positive

The medium-term outlook remains constructive. If IBM continues to execute well in enterprise software, AI and hybrid cloud, institutional investors resume accumulation, the stock could regain its broader uptrend. A breakout above key resistance levels would increase the probability of the stock revisiting and surpassing its previous highs.

Long-Term Outlook - Very Positive

IBM’s transformation into an enterprise AI and hybrid cloud leader significantly strengthens its long-term investment case. Supported by recurring software revenues, strong FCF, a robust dividend record and the expanding adoption of watsonx and Red Hat, IBM is well positioned to benefit from the global digital transformation trend.

For patient investors, IBM continues to offer an attractive combination of growth, stability and income.

Overall View: IBM remains a ‘Buy on Corrections’ candidate for long-term investors. While the short-term recovery still requires technical confirmation, the medium- and long-term risk-reward profile remains favorable.

Key Risks

• Slower enterprise IT spending

• AI competition from hyperscalers

• Execution risk in consulting

• Currency fluctuations

• Higher interest rates affecting corporate technology budgets

• Macroeconomic slowdown

Final Thoughts

IBM’s transformation from a legacy hardware company into a leading enterprise AI and hybrid cloud provider is steadily strengthening its long-term investment case. The recent correction appears to be a healthy consolidation after a strong rally rather than a sign of weakening fundamentals, allowing the stock to build a stronger base for its next move.

Technically, IBM is showing early signs of recovery, although a decisive breakout above the long-term GMMA, supported by stronger volumes, and renewed institutional buying. Such a breakout could open the path towards the US$330–350 range over the medium term, with the potential to achieve US$400–450 over the next 2–5 years if the company continues to execute well on its AI and hybrid cloud strategy.

For patient investors, the current consolidation may present an opportunity to accumulate a fundamentally strong business poised to benefit from the next phase of enterprise digital transformation.

Disclaimer: This article is intended solely for educational and informational purposes and should not be construed as investment advice or a recommendation to buy or sell any security. The analysis is based on the above chart and may change as market conditions evolve. Investors should conduct their own research and consider their financial objectives, risk tolerance, and consult a qualified financial advisor before making any investment decisions.

Let’s Talk: Do you believe IBM’s AI-led transformation and hybrid cloud strategy can drive the next leg of long-term growth, or will faster-growing technology companies continue to dominate the AI landscape? Share your thoughts and join the conversation.

Novo Nordisk A/S is a Denmark-based global pharmaceutical leader, and among the world’s largest manufacturers of diabetes and obesity-care medicines. The company operates primarily across Diabetes & Obesity Care and Rare Disease segments and employs about 78,500 people worldwide. It commands global leadership in the GLP-1 category through its blockbuster brands Ozempic and Wegovy.

Over the past decade, Novo Nordisk has been a central beneficiary of the global obesity-drug boom. However, 2025 proved to be its most challenging year, with the stock declining nearly 50% from its February peak due to rising competition, clinical setbacks, pricing pressures, and governance changes.

At the current market price of $57.47, the stock trades near multi-year lows, with a market capitalization of approximately $241.8 billion and a dividend yield of 2.23%. The 52-week range of $43.08–$93.80 highlights elevated volatility.

Major Strategic Developments

Launch of Oral Wegovy
In January 2026, Novo Nordisk launched the world’s first oral GLP-1 weight-loss pill, Wegovy, priced at $149 per month for self-pay U.S. patients. Clinical trials showed an average 16.6% weight loss over 64 weeks—on par with injectable Wegovy—while offering significantly greater convenience. The launch meaningfully expands Novo’s addressable patient base and could accelerate obesity drug adoption.

Wegovy Label Expansion into MASH
Wegovy received approval for metabolic dysfunction-associated steatohepatitis (MASH), a large and underpenetrated liver disease market. The only competing approved therapy, Rezdiffra, generated $637 million in the first nine months of 2025, underscoring the revenue potential of this new indication for Novo Nordisk.

Leadership and Governance Reset
In May 2025, the CEO was removed following concerns over market performance. Six months later, all independent board members resigned amid disagreements over U.S. strategy. Mike Doustdar has since assumed leadership and is leading the company’s restructuring and strategic reset.

China Patent Victory with Pricing Trade-off
In December 2025, China’s Supreme Court upheld Novo’s semaglutide patent protection. However, the company cut Wegovy prices by nearly 50% in several Chinese provinces to drive adoption, signaling increasing global pricing and margin pressures.

FINANCIAL PERFORMANCE & FUTURE GROWTH

For the first nine months of 2025, Novo Nordisk reported 290 billion DKK in revenue, reflecting 25% year-on-year growth, while earnings rose 20.70% to 101 billion DKK. Despite these numbers, repeated downward revisions to management guidance damaged investor confidence.

Analysts project revenue growth of 5% annually and earnings growth of 7.30% annually, marking a significant deceleration from prior years. The acquisition of Akero Therapeutics is expected to reduce 2026 operating profit growth by approximately 3 percentage points due to higher R&D spending. Patent expirations in select markets are also expected to have a low single-digit negative impact on global sales growth. Additionally, the acceptance of Medicare Part D pricing controls from January 2027 will place further pressure on U.S. margins.

Pipeline Strength

Novo Nordisk’s long-term growth depends heavily on its pipeline:

• CagriSema – Combination obesity and diabetes therapy; NDA filed

• Amycretin – Next-generation GLP-1 candidate showing strong Phase-2 efficacy

• UBT251 – Triple-agonist drug in early-stage development

Market Expansion Opportunity

The global obesity drug market is expected to exceed $100 billion by 2030. Novo Nordisk currently estimates that around 55 million Americans have Wegovy insurance coverage, including over 10 million Medicaid patients, placing the company in a strong position to benefit from rising obesity treatment adoption.

RISKS, VALUATION & INVESTMENT OUTLOOK

Novo Nordisk faced a perfect storm of negatives in 2025. Semaglutide trials failed to meet primary endpoints in Alzheimer’s disease, eliminating a potentially massive neurological market opportunity. Meanwhile, Eli Lilly’s Mounjaro and Zepbound rapidly gained market share, and Lilly’s oral GLP-1 candidate Orforglipron may gain FDA approval in 2026, threatening Novo’s first-mover advantage.

The U.S. market has also been disrupted by compounded copycat GLP-1 drugs sold through telehealth platforms, increasing price competition and regulatory scrutiny. Manufacturing and supply chain bottlenecks further contributed to repeated guidance downgrades. Combined with global pricing pressures, these challenges resulted in the worst stock performance in the company’s public history.

Valuation at Current Levels

• Forward P/E: 12.7x – 14x

• Sector average P/E: 17.6x – 18.4x

• Trailing EPS: $23.33

This places Novo Nordisk at a historically discounted valuation.

Outlook and Strategic Assumptions

Novo Nordisk’s recovery will depend on the successful rollout of oral Wegovy and the stabilisation of market share in its core obesity franchise. The newly approved MASH indication adds an important incremental growth avenue and strengthens the long-term monetisation potential of Wegovy.

Over the longer term, continued expansion of the global obesity treatment market, combined with the successful commercialisation of next-generation therapies such as CagriSema and broader pipeline progress, will be key to sustaining growth. Improved operational execution and pricing discipline will remain critical to restoring margins and investor confidence, positioning Novo Nordisk to reinforce its leadership in metabolic and obesity care.

Final Verdict

At current levels, Novo Nordisk offers attractive long-term risk-reward. While near-term volatility remains high due to competition and pricing pressure, much of the downside appears priced in. Long-term investors willing to tolerate volatility may find current valuations an attractive entry point.

Disclaimer
This research is intended solely for educational purposes and should not be interpreted as investment advice. Readers are encouraged to conduct their own due diligence and/or consult a licensed financial advisor before making any investment decisions. All information and data presented are sourced from publicly available company filings, analyst reports, and third-party sources believed to be reliable. While this report has been prepared independently, the views expressed are personal and may contain errors or subjective bias. The author holds no financial or personal interest in the company discussed and does not own any position at the time of writing.

Power Solutions International (PSIX) occupies a rare position at the intersection of exceptional revenue momentum and persistent investor skepticism. The company has emerged as a meaningful beneficiary of the AI-led data-center infrastructure cycle, delivering record revenues and triple-digit earnings growth in FY2025.

Despite this performance, PSIX trades at approximately 12.4x trailing earnings, a steep discount to industrial and growth peers. This valuation gap reflects sustained concerns around earnings quality, governance credibility, and disclosure risk. While upside potential remains meaningful if these concerns abate, the burden of proof has firmly shifted to management.

Company Overview

Power Solutions International, Inc. designs, engineers, manufactures, and markets emission-certified engines and integrated power systems for global markets. Headquartered in Wood Dale, Illinois, the company operates across North America, Europe, Asia-Pacific, and other international regions.

As a subsidiary of Weichai America Corp., PSIX offers:

• Packaged power systems and generator sets

• Compression-ignition and spark-ignition engines

• Power solutions for data centers, oil & gas, industrial equipment, and transportation

The company employs approximately 700 people and has strategically repositioned itself toward high-growth data-center and AI-infrastructure demand, now its primary growth driver.

Recent Financial Performance

Q3 FY2025: Record Results

PSIX delivered materially stronger-than-expected Q3 FY2025 results:

• Revenue: USD 203.8 million (+62% YoY; vs. USD 169.2m estimated)

• Net Income: USD 27.6 million (+59% YoY)

Nine-month FY2025 performance:

• Net Sales: USD 531.2 million (+60% YoY)

• Net Income: USD 97.9 million (+113% YoY)

Growth was primarily driven by an USD 85.3 million year-over-year increase in power-systems revenue, largely attributable to hyperscale and AI-related data-center demand.

Strategic Developments

• August 2025: Secured a USD 135 million committed credit facility, extending maturities to July 2027 and strengthening liquidity

• August 2025: Entered a strategic cooperation agreement with HD Hyundai Infracore to expand industrial engine offerings

• September 2025: Appointed Zhaoying (Dorothy) Du as General Counsel and Corporate Secretary

• October 2025: Board restructuring with increased Weichai-affiliated director representation

These actions signal an effort to reinforce operational capacity and governance structure amid accelerated growth.

Margin Compression & Earnings Quality

Despite record top-line performance, profitability indicators have weakened:

• Gross margin: Declined from ~29% to ~23% (≈500 bps contraction)

• Operating cash flow: Underperformed relative to reported net income

• Accounts receivable: Growing faster than revenues, raising working-capital concerns

Management attributes margin pressure to product-mix shifts toward lower-margin data-center solutions and temporary inefficiencies during rapid capacity expansion. However, the persistence of these trends continues to weigh on investor confidence.

Major Risk Factors

1. Securities Law Investigations

Multiple law firms-initiated investigations during November–December 2025, focusing on guidance consistency, disclosure adequacy, and earnings transparency.

2. Historical Accounting Overhang

The company’s former CEO was charged with accounting fraud in 2019, leading to SEC settlements in 2020. Although related to prior management, this history amplifies sensitivity to current disclosure issues.

3. Competitive Landscape

PSIX competes against industry leaders such as Cummins, Caterpillar, and Generac, all of which possess superior scale, customer relationships, and pricing power.

4. Customer Concentration

Heavy exposure to the data-center segment increases vulnerability to hyperscaler capex cycles and potential demand normalization.

Investment Thesis

PSIX is currently consolidating near USD 68.73, following a decisive recovery from recent lows, with early indications of renewed bullish momentum. From a technical standpoint, the stock continues to display constructive trend-reversal characteristics, though its wide 52-week trading range underscores elevated volatility. Sustained price action above key cloud and trend support levels remains critical to preserving a bullish bias.

Outlook

• Short Term (1–3 months):
  Positively biased, with momentum favoring further upside as long as the stock holds above USD 60, supported by improving technical structure and consolidation strength.

• Medium Term (3–9 months):
  Constructively bullish, contingent on confirmation of earnings durability, margin stabilization, and improved cash-flow visibility. Successful fundamental validation could support a continuation of the recovery trend.

• Long Term (9–24 months):
  Bullish with selective conviction, driven by sustained AI and data-center infrastructure demand, provided governance credibility strengthens and operational execution remains consistent.

While volatility remains a defining feature of PSIX, disciplined risk management and adherence to key support levels significantly improve the risk-reward profile across time horizons.

Conclusion & Recommendation

PSIX represents a high-growth but high-uncertainty investment opportunity BUT:

Investors should also eye:

• Q4 FY2025 results validating guidance

• Evidence of margin stabilization and cash-flow alignment

• Resolution or dismissal of securities investigations and demonstrable improvements in governance and disclosure practices

Until this, PSIX limits margin of safety, despite its attractive headline growth and discounted valuation.

Disclaimer

This research is intended solely for educational purposes and should not be interpreted as investment advice. Readers are encouraged to conduct their own due diligence and/or consult a licensed financial advisor before making any investment decisions. All information and data presented are sourced from publicly available company filings, analyst reports, and third-party sources believed to be reliable. While this report has been prepared independently, the views expressed are personal and may contain errors or subjective bias. The author holds no financial or personal interest in the company discussed and does not own any position at the time of writing.

Company Overview & Investment Snapshot

Pagaya Technologies Ltd. is an AI-driven credit infrastructure company focused on expanding access to consumer lending by reassessing borrowers rejected by traditional banks. Founded in 2016 and headquartered in New York, the company partners with fintechs and financial institutions to originate loans and distribute them to institutional investors via securitizations and related structures, largely avoiding balance-sheet credit risk.

While Pagaya has delivered strong revenue growth, record securitization activity, and a recent return to GAAP profitability, its risk profile remains elevated. Large historical losses, extreme share-price volatility, insider selling, and sensitivity to credit and capital-market cycles continue to weigh on investor confidence.

After a sharp correction from peak levels, the stock trades at forward valuations that appear reasonable but remain highly execution dependent.

Recent Developments & Operating Momentum

Pagaya posted a solid Q3 2025, reporting record revenue of $350.17 million and net income of $22.55 million, reflecting meaningful improvement after years of losses. Management raised full-year guidance, projecting network volume of up to $10.75 billion. This progress follows FY2024, when revenue rose 27% to $1billion plus but net losses widened to $401 million, highlighting profitability concerns.

Capital markets activity remained strong, with a $500 million consumer-loan ABS transaction in December 2025, its eighth of the year—bringing 2025 capital commitments above $8 billion and total ABS issuance to $7.6 billion. Liquidity was further supported by expansion of the revolving credit facility to $132 million at lower cost and issuance of $500 million senior unsecured notes at 8.875% due 2030, improving near-term flexibility while increasing leverage.

Growth Outlook & Market Expectations

Street estimates project revenue of approximately $1.8 billion by 2028, implying a CAGR of about 17%, with potential net income of roughly $312 million assuming operating leverage and stable credit performance. Pagaya reported GAAP net income of $17 million in Q2 2025 and followed with another profitable quarter, suggesting a possible inflection point. Management guides to FY2025 GAAP net income of $55–$75 million.

Analyst sentiment remains constructive, with a consensus “Strong Buy” rating and average 12-month price targets in the $37–$40 range, spanning from approx $27 on the low end to $54 on the high.

Key Risks & Structural Concerns

Notwithstanding recent improvements, Pagaya faces material risks. Net losses of $401 million in 2024 raise concerns over cost discipline and the durability of profitability. The stock remains highly volatile, trading roughly 45–50% below recent highs, while insider selling over the past three months totalled 97,425 shares across nine transactions.

The business is also exposed to partner concentration and subprime credit risk, where any pullback in partner activity or economic downturn could materially impact volumes and performance. In addition, evolving regulation of AI-based underwriting and competition may pressure margins and growth.

Valuation & Price Targets

As of December 2025, Pagaya trades in the $22–$24 range, implying a market capitalization of approximately $2 billion and a 52-week range of $8–$45. While valuation metrics appear modest relative to high-growth fintech peers, they assume sustained profitability and benign credit conditions.

• Medium-term (12–18 months): Upside potential of ~25–40% under stable credit conditions, with downside risk to $18–$20 if execution or credit trends weaken.

• Long-term (3–5 years): A valuation of $35–$45 is achievable, if demonstrates sustained GAAP profitability, scales revenue, and reduces partner and credit-cycle risks.

Technical view and Chart positioning

The stock has moved from a strong uptrend into a healthy correction and is now showing signs of stabilization. Technically, selling pressure has eased, volatility has reduced, and short-term averages are flattening, indicating early base formation rather than continued weakness. From an investment perspective, downside risk appears to be moderating, but a clear upside trend will only be confirmed if the price sustains above ₹31–32 with volume. The setup favors cautious accumulation or watchlist positioning rather than aggressive buying.

Investment View & Conclusion

Pagaya represents a high-risk, high-reward exposure to AI-enabled consumer credit infrastructure. Recent operational progress and profitability are encouraging, but they remain overshadowed by historical losses, volatility, insider selling, and exposure to subprime credit cycles. The roughly 50% correction from recent highs suggests growing market skepticism.

View: Suitable for investors with high risk tolerance. Existing shareholders may consider holding with disciplined risk management, while new investors should await and accumulate either lower entry levels or clearer evidence of sustainable profitability across economic cycles.

Disclaimer
This research is intended solely for educational purposes and should not be interpreted as investment advice. Readers are encouraged to conduct their own due diligence and/or consult a licensed financial advisor before making any investment decisions. All information and data presented are sourced from publicly available company filings, analyst reports, and third-party sources believed to be reliable. While this report has been prepared independently, the views expressed are personal and may contain errors or subjective bias. The author holds no financial or personal interest in the company discussed and does not own any position at the time of writing.

Stantec Inc. is a global leader in sustainable engineering, architecture, and environmental consulting and provides integrated services to public- and private-sector clients across infrastructure, buildings, environmental services, water, and energy & resources.

Stantec has delivered consistent financial strength, robust backlog expansion, and exposure to long-term structural growth themes. This refined two-page report summarizes its financial performance, outlook, risks, and valuation.

2024 Performance Highlights

• Net Revenue: $5.9B, up 15.8% YoY: Adjusted EBITDA Margin: 16.7%

Q3 2025 Results: Strong Numbers, Weak Sentiment

• Net Revenue: $1.7B (+11.8% YoY); Adjusted EPS: $1.53 (+39% beat)

• Adjusted EBITDA Margin: 19.0%: Operating Cash Flow: $551M YTD (+86%)

Stantec’s 2025 growth was supported by three strategic acquisitions—Page, Ryan Hanley and Cosgroves — which collectively helped lift the company’s full-year revenue growth guidance from 7–10% to 10–12%. However, this expansion also increased reliance on acquisition-driven growth and added complexity to integration efforts.

Growth Outlook

2025 Management Guidance

• Revenue Growth: 10–12%

• Adjusted EBITDA Margin: 17.2–17.5%

• Adjusted EPS Growth: 18.5–21.5%

Long-Term Growth Drivers

• Multi-year US Infrastructure Investment and Jobs Act (IIJA) tailwinds

• Over 100 active data-center projects

• Strong demand for water infrastructure (double-digit growth)

• Rising environmental & energy transition engineering needs

Analyst Consensus

• 12-Month Target: C$169.89 (+26% upside)

• Rating: Strong Buy (7/7 analysts)

• Projected 2028 Revenue: C$8.2B

Risks & Concerns

Premium Valuation: Stantec trades at a premium relative to peers and leaves little room for operational missteps or slower growth.

Slowing US Organic Growth: The United States accounts for over 52% of its revenue. Flat US backlog growth and prolonged procurement cycles reduce near-term visibility and could limit momentum.

Margin Compression Risk: Seasonally weaker Q4 performance combined with integration expenses could reduce margins by 30–40 bps, potentially pressuring near-term earnings.

Competitive Pressure from WSP Global: WSP, a significantly larger and more diversified competitor, has delivered superior 10-year shareholder returns and poses a persistent competitive threat.

Long-Term Targets

• Base Case: C$165–185

• Bull Case: C$210–240

• Risk-Adjusted Long-Term Target: C$175, implying 9–11% annual returns

Final Conclusion

Stantec remains a high-quality engineering and design leader with strong exposure to long-duration growth themes such as infrastructure renewal, water management, environmental services, and data centers. Company’s backlog strength and disciplined execution support a favorable long-term narrative.

However, at current levels, the stock’s valuation premium, slowing US growth, and integration uncertainties tilt the near-term risk-reward balance to the downside.

A pullback toward C$115–120 would provide a more compelling entry point, aligning valuation with sustainable growth expectations.

Agnico Eagle Mines Ltd. is one of the world’s leading gold producers with operations in Canada, Australia, Finland, and Mexico, supported by exploration in Latin America and the U.S. The 2022 merger with Kirkland Lake Gold strengthened its long-life portfolio with Detour Lake, Macassa, and the high-grade Fosterville mine.

Agnico’s Tier-1 jurisdiction exposure, strong reserve base, and growth pipeline position it as a high-quality senior gold miner—though current valuation leaves limited margin for error.

Recent Performance & Strategic Developments

Q3 2025: Record Results

Agnico reported one of its strongest quarters:

• EPS: $2.16 vs. $1.95 (10.8% beat): Revenue: $3.06B vs. $2.95B

• Free Cash Flow: $1.2B: Debt Reduction: $400M repaid

The company also launched Avenir Minerals, holding $80M in critical mineral assets with $50M additional funding.

Key Risks & Emerging Challenges

· The stock trades at a premium to DCF fair value (intrinsic value and above peer multiples.

· Gold Price pullback could Erode margins, Reduce cash flows and Trigger sentiment reversal.

Technical Positioning & Market Structure

Agnico Eagle remains in a strong uptrend within a well-defined ascending channel, though the stock is now trading near the upper boundary, suggesting stretched conditions and ongoing consolidation around CAD 243–244.

Volume continues to support the trend, and momentum remains bullish, but indicators are entering overbought territory, limiting near-term upside without a fresh catalyst.

Medium-Term Target

Agnico Eagle’s medium-term target of CAD 260–285 is supported by the potential for a breakout above CAD 245, gold prices holding above USD 3,800/oz, and production growth from the Hope Bay restart and Detour Underground ramp-up.

Analyst targets averaging around CAD 273 and strong earnings momentum also reinforce the outlook. However, risks such as stretched valuation, ongoing ESG issues, inflationary cost pressures, and commodity volatility remain significant.

Long-Term Target

Agnico Eagle’s long-term target of CAD 320–380 is supported by a bullish outlook for gold potentially rising to USD 4,200–5,400/oz, with extreme scenarios reaching USD 6,200. The ramp-up of Hope Bay and Detour Underground—adding over 300,000 oz annually—combined with future free cash flow potential exceeding $2B per year, strengthens the multi-year growth case.

Long-term technical projections also point toward the CAD 350–380 zone. The outlook carries an estimated 50% probability, highly dependent on a sustained gold Supercycle and consistent operational execution.

Investment View: A High-Quality Miner at a High-Stakes Moment

Agnico remains a high-quality operator with strong assets, rising production, and supportive gold market tailwinds, but the current valuation assumes a near-perfect backdrop of strong gold prices, flawless execution, and smooth ESG outcomes.

Existing investors can maintain their positions and New investors should avoid chasing the rally and look to accumulate only on meaningful pullbacks toward CAD 210–220, or modest dips to 220–230. In summary: an excellent business at an elevated price—upside remains, but downside risks also open.

Disclaimer
This research is intended solely for educational purposes and should not be interpreted as investment advice. Readers are encouraged to conduct their own due diligence and/or consult a licensed financial advisor before making any investment decisions. All information and data presented are sourced from publicly available company filings, analyst reports, and third-party sources believed to be reliable. While this report has been prepared independently, the views expressed are personal and may contain errors or subjective bias. The author holds no financial or personal interest in the company discussed and does not own any position at the time of writing.